|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.120 USD | -.--% |
|
-.--% | -22.76% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Performance
| 3 months | -18.25% | ||
| 6 months | -22.76% | ||
| Current year | -22.76% | ||
| 1 year | -11.11% | ||
| 3 years | -74.89% | ||
| 5 years | -93.92% | ||
| 10 years | -92.45% |
Volumes
marketsDaily volume
192
Estimated daily volume
192
Avg. Volume 20 sessions
200
Daily volume ratio
0.96
Avg. Volume 20 sessions USD
224
Record volume 1
79,004
Record volume 2
79,004
Record volume 3
46,800
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
46,552,996
Net sales (EUR)
1,174,000
Net sales (USD)
1,336,673
Number of employees
31
Sales / Employee (EUR)
37,871
Sales / Employee (USD)
43,118
Free-Float
63.24 %
Free-Float capitalization (USD)
26,904,563
Average Daily Capital Traded
0%
Indicators
Moving average 20 days
0.4425
Moving average 50 days
0.177
Moving average 100 days
1.203
Price spread / (MMA20)
-60.49%
Price spread / (MMA50)
-84.20%
Price spread / (MMA100)
+7.44%
RSI 9 days
44.02
RSI 14 days
46.1
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -11.11% | -74.89% | 46.55M | |
| +0.45% | +2.80% | +54.73% | +22.34% | 324B | |
| -0.07% | +2.09% | +23.58% | -11.87% | 68.88B | |
| +1.35% | +5.29% | +40.68% | +87.27% | 9.72B | |
| +1.01% | -0.53% | +2.70% | -2.81% | 8.37B | |
| +1.13% | +1.51% | -21.44% | -4.05% | 4.32B | |
| +4.90% | +5.79% | -38.81% | +21.37% | 3.83B | |
| -4.00% | +0.71% | -5.66% | +12.85% | 3.62B | |
| -2.10% | -3.83% | +37.58% | +53.03% | 2.68B | |
| -4.07% | -2.45% | -8.03% | -10.93% | 2.04B | |
| Average | -0.15% | +1.42% | +7.42% | +9.23% | 42.72B | |
| Weighted average by Cap. | +0.37% | +2.63% | +45.83% | +17.47% |
Historical Quotes: AB Science
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| Current year | 1.12 |  | 1.37 |
| 1 year | 1.12 | | 1.45 |
| 3 years | 0 | | 3.84 |
| 5 years | 0 | | 17.1 |
| 10 years | 0 | | 26.7 |
Monthly variations
Annual variations
| 2026 | -22.76% | ||
| 2025 | +61.11% | ||
| 2024 | +89,999,900.00% | ||
| 2023 | -100.00% | ||
| 2022 | -32.69% | ||
| 2021 | -43.08% | ||
| 2020 | +298.14% | ||
| 2019 | +44.61% | ||
| 2018 | -55.60% | ||
| 2017 | -35.19% | ||
| 2016 | -2.61% | ||
| 2015 | +2.75% | ||
| 2014 | -24.22% | ||
| 2013 | -18.66% |
- Stock Market
- Stocks
- AB Stock
- ABSCF Stock
- Quotes AB Science
Select your edition
All financial news and data tailored to specific country editions
